Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Express Scripts
Harvard Business School
Fuji
UBS
Accenture
Boehringer Ingelheim
Covington
Citi

Generated: May 23, 2018

DrugPatentWatch Database Preview

LOCORTEN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Locorten, and what generic alternatives are available?

Locorten is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in LOCORTEN is flumethasone pivalate. There are eleven drug master file entries for this compound. Additional details are available on the flumethasone pivalate profile page.
Summary for LOCORTEN
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 33
Patent Applications: 1,292
DailyMed Link:LOCORTEN at DailyMed
Drug patent expirations by year for LOCORTEN
Medical Subject Heading (MeSH) Categories for LOCORTEN
Synonyms for LOCORTEN
[2-[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] 2,2-dimethylpropanoate
[2-[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 2,2-dimethylpropanoate
002F291
0DV09X6F21
2-[(1R,2S,8S,10S,11S,13R,14R,15S,17S)-1,8-difluoro-14,17-dihydroxy-2,13,15-trimethyl-5-oxotetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-3,6-dien-14-yl]-2-oxoethyl 2,2-dimethylpropanoate
2-[(1R,2S,8S,10S,11S,13R,14R,15S,17S)-1,8-DIFLUORO-14,17-DIHYDROXY-2,13,15-TRIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL]-2-OXOETHYL 2,2-DIMETHYLPROPANOATE
2002-29-1
6,9-Difluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl pivalate
6.Alpha.,9-Difluoro-11.beta.,17,21-trihydroxy-16.a
6.Alpha.,9-Difluoro-11.beta.,17,21-trihydroxy-16.alpha.-methylpregna-1,4-diene-3,20-dione 21-pivalate
6.Alpha.,9.alpha.-Difluoro-16.alpha.-methylprednisolone 21-pivalate
6alpha,9-difluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregna-1,4-dien-21-yl 2,2-dimethylpropanoate
6alpha,9-Difluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-(2,2-dimethylpropionate)
6alpha,9-Difluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-pivalate
6alpha,9alpha-Difluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione, 21-pivalate
6alpha,9alpha-Difluoro-16alpha-methylprednisolone 21-pivalate
AC-2070
AC1L9FI1
AKOS015964841
BC219283
C-54952
C27H36F2O6
CCG-221256
CHEBI:31620
CHEMBL1200877
D01464
D0F7NQ
EINECS 217-901-1
Flumetasone 21-pivalate
Flumetasone pivalate
Flumetasone pivalate (JAN/BAN)
Flumethasome pivalate
Flumethasone 21-pivalate
FLUMETHASONE PIVALATE
Flumethasone pivalate (USP)
Flumethasone pivalate [USAN:USP]
Flumethasone pivalate, British Pharmacopoeia (BP) Reference Standard
Flumethasone pivalate, European Pharmacopoeia (EP) Reference Standard
Flumethasone pivalate, United States Pharmacopeia (USP) Reference Standard
Flumethasone-21-pivalate
Flumethsone pivalate
Flumethsone pivalate
FT-0626441
GTPL7075
HMS2231D24
KS-1138
Locacorten
Locorten (TN)
Lorinden
lpha.-methylpregna-1,4-diene-3,20-dione 21-pivalate
MLS000069558
MLS001077304
MolPort-002-885-878
NCGC00022408-03
NSC 107680
NSC107680
Opera_ID_1461
PL009849
Pregna-1,4-diene-3,20-dione, 21-(2,2-dimethyl-1-oxopropoxy)-6,9-difluoro-11, 17-dihydroxy-16-methyl-, (6.alpha.,11.beta.,16.alpha.)-
Pregna-1,4-diene-3,20-dione, 21-(2,2-dimethyl-1-oxopropoxy)-6,9-difluoro-11,17-dihydroxy-16-methyl-, (6alpha,11beta,16alpha)-
Pregna-1,4-diene-3,20-dione, 6-alpha,9-difluoro-11-beta,17,21-trihydroxy-16-alpha-methyl-, 21-pivalate
Pregna-1,4-diene-3,20-dione, 6alpha,9-difluoro-11beta,17,21-trihydroxy-16alpha-methyl-, 21-pivalate (8CI)
Q-101376
Q560
SC-66562
SCHEMBL6968
SMR000058824
UNII-0DV09X6F21
ZINC3977985

US Patents and Regulatory Information for LOCORTEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis LOCORTEN flumethasone pivalate CREAM;TOPICAL 016379-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
US Department of Justice
Argus Health
Dow
Chubb
Cantor Fitzgerald
McKinsey
Julphar
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.